Hubert Yin's Publications
This folder holds the following references to publications, sorted by year and author.
There are 17 references in this bibliography folder.
Slivka, PF, Shridhar, M, Lee, G, Sammond, DW, Hutchinson, MR, Martinko, AJ, Buchanan, MM, Sholar, PW, Kearney, JJ, Harrison, JA, Watkins, LR, and Yin, H
(2009).
A peptide antagonist of the TLR4-MD2 interaction.
Chembiochem, 10(4):645-9.
Tang, J, Yin, H, Qiu, J, Tucker, MJ, DeGrado, WF, and Gai, F
(2009).
Using two fluorescent probes to dissect the binding, insertion, and dimerization kinetics of a model membrane peptide.
J Am Chem Soc, 131(11):3816-7.
Li, Y, Chase, AR, Slivka, PF, Baggett, CT, Zhao, TX, and Yin, H
(2008).
Design, synthesis, and evaluation of biotinylated opioid derivatives as novel probes to study opioid pharmacology.
Bioconjug Chem, 19(12):2585-9.
Slivka, PF, Wong, J, Caputo, GA, and Yin, H
(2008).
Peptide probes for protein transmembrane domains.
ACS Chem Biol, 3(7):402-11.
Yin, H, Slusky, JS, Berger, BW, Walters, RS, Vilaire, G, Litvinov, RI, Lear, JD, Caputo, GA, Bennett, JS, and DeGrado, WF
(2007).
Computational design of peptides that target transmembrane helices.
Science, 315(5820):1817-22.
Yin, H, Frederick, KK, Liu, D, Wand, AJ, and Degrado, WF
(2006).
Arylamide derivatives as peptidomimetic inhibitors of calmodulin.
Org Lett, 8(2):223-5.
Yin, H, Gerlach, LO, Miller, MW, Moore, DT, Liu, D, Vilaire, G, Bennett, JS, and DeGrado, WF
(2006).
Arylamide derivatives as allosteric inhibitors of the integrin alpha2beta1/type I collagen interaction.
Bioorg Med Chem Lett, 16(13):3380-2.
Yin, H, Litvinov, RI, Vilaire, G, Zhu, H, Li, W, Caputo, GA, Moore, DT, Lear, JD, Weisel, JW, Degrado, WF, and Bennett, JS
(2006).
Activation of platelet alphaIIbbeta3 by an exogenous peptide corresponding to the transmembrane domain of alphaIIb.
J Biol Chem, 281(48):36732-41.
Chen, L, Yin, H, Farooqi, B, Sebti, S, Hamilton, AD, and Chen, J
(2005).
p53 alpha-Helix mimetics antagonize p53/MDM2 interaction and activate p53.
Mol Cancer Ther, 4(6):1019-25.
Yin, H and Hamilton, AD
(2005).
Strategies for targeting protein-protein interactions with synthetic agents.
Angew Chem Int Ed Engl, 44(27):4130-63.
Yin, H, Lee, G, Park, HS, Payne, GA, Rodriguez, JM, Sebti, SM, and Hamilton, AD
(2005).
Terphenyl-based helical mimetics that disrupt the p53/HDM2 interaction.
Angew Chem Int Ed Engl, 44(18):2704-7.
Yin, H, Lee, G, Sedey, KA, Kutzki, O, Park, HS, Orner, BP, Ernst, JT, Wang, H, Sebti, SM, and Hamilton, AD
(2005).
Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
J Am Chem Soc, 127(29):10191-6.
Yin, H, Lee, G, Sedey, KA, Rodriguez, JM, Wang, H, Sebti, SM, and Hamilton, AD
(2005).
Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.
J Am Chem Soc, 127(15):5463-8.
Yin, H and Hamilton, AD
(2004).
Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein.
Bioorg Med Chem Lett, 14(6):1375-9.
Ernst, JT, Becerril, J, Park, HS, Yin, H, and Hamilton, AD
(2003).
Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex.
Angew Chem Int Ed Engl, 42(5):535-9.
Sun, J, Ohkanda, J, Coppola, D, Yin, H, Kothare, M, Busciglio, B, Hamilton, AD, and Sebti, SM
(2003).
Geranylgeranyltransferase I inhibitor GGTI-2154 induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice.
Cancer Res, 63(24):8922-9.
Kutzki, O, Park, HS, Ernst, JT, Orner, BP, Yin, H, and Hamilton, AD
(2002).
Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry.
J Am Chem Soc, 124(40):11838-9.
